Correlation Between X4 Pharmaceuticals and Entero Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between X4 Pharmaceuticals and Entero Therapeutics,, you can compare the effects of market volatilities on X4 Pharmaceuticals and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Entero Therapeutics,.

Diversification Opportunities for X4 Pharmaceuticals and Entero Therapeutics,

-0.46
  Correlation Coefficient

Very good diversification

The 3 months correlation between XFOR and Entero is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Entero Therapeutics, go up and down completely randomly.

Pair Corralation between X4 Pharmaceuticals and Entero Therapeutics,

Given the investment horizon of 90 days X4 Pharmaceuticals is expected to generate 0.69 times more return on investment than Entero Therapeutics,. However, X4 Pharmaceuticals is 1.45 times less risky than Entero Therapeutics,. It trades about 0.0 of its potential returns per unit of risk. Entero Therapeutics, is currently generating about -0.04 per unit of risk. If you would invest  78.00  in X4 Pharmaceuticals on August 26, 2024 and sell it today you would lose (44.00) from holding X4 Pharmaceuticals or give up 56.41% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

X4 Pharmaceuticals  vs.  Entero Therapeutics,

 Performance 
       Timeline  
X4 Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days X4 Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Entero Therapeutics, 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Entero Therapeutics, are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Entero Therapeutics, displayed solid returns over the last few months and may actually be approaching a breakup point.

X4 Pharmaceuticals and Entero Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with X4 Pharmaceuticals and Entero Therapeutics,

The main advantage of trading using opposite X4 Pharmaceuticals and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.
The idea behind X4 Pharmaceuticals and Entero Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon